The round was led by HealthCare Royalty Partners and included other high-profile venture capital firms.
Invuity will use the funds to promote sales of its product line of minimally invasive devices for spine, breast, thyroid and plastic surgeries, as well as other procedures.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
